U.S. Markets open in 43 hrs, 5 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 0.81 01:51 PM EDT | |
|---|---|---|
| Day High | 0.84 09:30 AM EDT |
|
| Range | 0.03 |
| Volume | 12,600 | |
|---|---|---|
| 30-Day Avg Vol | 18,000 |
|
| Difference | -30.00% |
| Market Cap | 40.80 M | |
|---|---|---|
| Mkt Cap Chg | -1.99 M |
| Shares Out | 49.76 M | |
|---|---|---|
| % Shrs Traded | 0.03% | |
| 1yr EPS Est | -0.42 |
| 52-Wk Low | 0.73 5/6/09 | |
|---|---|---|
| 52-Wk High | 2.43 8/7/08 |
|
| Range | 1.70 |
| Prev Close | 0.8599 7/1/09 | |
|---|---|---|
| Today's Open | 0.84 | |
| Change | -2.31% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 3,271.00 |
| Revenue (LFY) | 209,000 | |
|---|---|---|
| Earnings (LFY) | -20.06 M | |
| Earnings (MRQ) | -5.45 M | |
| Next Earn Est | -0.107 | |
| Next Earnings | 08/10/2009 |
|
| EPS (TTM) | -0.44 | |
| 1yr EPS Growth | 4.55% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -1.00 | |
| PEG Ratio | -0.03 | |
| Return on Equity | -103.01 | |
| Beta | 0.39 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Corcept Therapeutics wants to help people who are beyond blue. The biotechnology firm is exploring treatments that regulate the presence of Cortisol, a steroid hormone associated with some psychiatric ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.107 8/10/09 | — — |
—
—
|
| Last Quarter | -0.10 3/31/09 | -0.11 3/31/09 |
-0.01
Missed
|
| 2 Quarters Ago | -0.11 12/31/08 | -0.13 12/31/08 |
-0.02
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 24,000.00 | 209,000.00 |
| Gross Profit | 0.00 | 197,000.00 |
| Operating Income | -5.53 M | -19.69 M |
| Net Income | -5.45 M | -20.06 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts